Cell encapsulation: technical and clinical advances

Gorka Orive, Edorta Santos, Denis Poncelet, Rosa María Hernández, José Luis Pedraz, Lars U Wahlberg, Paul De Vos, Dwaine Emerich

Research output: Contribution to journalReview articlepeer-review

131 Citations (Scopus)

Abstract

Treating many chronic diseases will require a tight, minute-to-minute regulation of therapeutic molecules that is currently not achievable with most pharmaceutical therapies. For these diseases, implantable living cellular systems may be able to provide unlimited drug delivery, enabling seamless matching of treatment duration with disease longevity. Cell encapsulation is an advanced technology that achieves this goal and represents a viable therapeutic option. The advanced state of the field has allowed researchers to inch forward into therapeutic domains previously untouchable because of the myriad disparate fields that intersect biomaterials and cells. Here, we discuss the next generation of clinical trials and potential approaches, 'smart' and responsive encapsulation systems, sophisticated and multifunctional devices, and novel imaging tools, together with the future challenges in the field.

Original languageEnglish
Pages (from-to)537-546
Number of pages10
JournalTrends in Pharmacological Sciences
Volume36
Issue number8
DOIs
Publication statusPublished - Aug-2015

Keywords

  • NERVE GROWTH-FACTOR
  • HYDROGEL SHELL MICROCAPSULES; ALGINATE-BASED MICROCAPSULES
  • ALGINATE-BASED MICROCAPSULES
  • NERVE GROWTH-FACTOR; HYDROGEL SHELL MICROCAPSULES; AMINIATURIZED 3D CULTURE
  • NERVE GROWTH-FACTOR; HYDROGEL SHELL MICROCAPSULES; ALGINATE-BASED MICROCAPSULES; MINIATURIZED 3DTYPE-1 DIABETIC-PATIENT
  • NERVE GROWTH-FACTOR; HYDROGEL SHELL MICROCAPSULES; ALGINATE-BASED MICROCAPSULES; MINIATURIZED 3D CULTURE; TYPE-1 DIABETIC-PATIENT;PANCREATIC-ISLET CELLS
  • NERVE GROWTH-FACTOR; HYDROGEL SHELL MICROCAPSULES; ALGINATE-BASED MICROCAPSULES; MINIATURIZED 3D CULTURE; TYPE-1 DIABETIC-PATIENT; PANCREATIC-ISLET CELLSPLURIPOTENT STEM-CELLS
  • POLY-L-LYSINE
  • GENE-THERAPY
  • NERVE GROWTH-FACTOR; HYDROGEL SHELL MICROCAPSULES; ALGINATE-BASED MICROCAPSULES; MINIATURIZED 3D CULTURE; TYPE-1 DIABETIC-PATIENT; PANCREATIC-ISLET CELLS; PLURIPOTENT STEM-CELLS; POLY-L-LYSINE; GENE-THERAPY;NONIMMUNOSUPPRESSED PATIENTS

Cite this